In a groundbreaking study, researchers utilized single-cell RNA sequencing to analyze the gene expression profiles of individual human embryonic stem cells as they underwent a 60-day differentiation protocol. This innovative approach not only enabled the mapping of transient states during the cells’ transformation into retinal pigment cells but also led to the optimization of the protocol to suppress the growth of non-RPE cells. By preventing the formation of contaminant cell populations, the researchers aim to ensure that the cells intended for transplantation are pure and closely resemble the original RPE cells from the patient’s eye. This meticulous optimization is crucial in streamlining stem cell therapies for macular degeneration, offering new hope for more effective and targeted treatments in the future.
Read more about this — here
